Drug name - Trudhesa
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9550036 | IMPEL NEUROPHARMA | Nasal drug delivery device |
Sep, 2032
(9 years from now) | |
| US10507295 | IMPEL NEUROPHARMA | Nasal drug delivery device |
Dec, 2032
(10 years from now) | |
| US10940278 | IMPEL NEUROPHARMA | Nozzles for nasal drug delivery |
Jan, 2033
(10 years from now) | |
| US9919117 | IMPEL NEUROPHARMA | Nozzles for nasal drug delivery |
Mar, 2033
(10 years from now) | |
| US11185497 | IMPEL NEUROPHARMA | Intranasal delivery of dihydroergotamine by precision olfactory device |
Jan, 2039
(16 years from now) | |
Drugs and Companies using DIHYDROERGOTAMINE MESYLATE ingredient
Treatment: Nasal administration of dihydroergotamine mesylate by metered spray for the acute treatment of migraine with or without aura
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.725MG/SPRAY | SPRAY, METERED;NASAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.